Pharmafile Logo
Pharmafocus logo
Advanced Search

pharmaceutical

Showing 15 posts of 792 posts found.

lilly2_web

Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018
Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …

News
soil-3301161_960_720

Lodo and Roche go digging for drug candidates, after $1bn deal

May 10, 2018
Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …

News

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

News

GSK’s CFO chooses to exit company

May 9, 2018
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position …

News
bald_man

Old osteoporosis drug could be used to treat hair loss

May 9, 2018
Research and Development biotech, drugs, hair loss, pharma, pharmaceutical

Researchers from the University of Manchester’s Centre for Dermatology Research have made a breakthrough towards the holy grail of the …

News
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018
Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

News
baby-784607_960_720

Mallinckrodt gets two thumbs down from FDA for jaundice drug

May 4, 2018
Medical Communications, Sales and Marketing InfaCare, Mallinckrodt, biotech, drugs, pharma, pharmaceutical

Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …

News
webinar

Free webinar – Rational EU risk management for oncology medicines

May 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA Group, biotech, drugs, pharma, pharmaceutical

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …

News
bms

BMS looks to leverage real-world data, with Flatiron collab

May 3, 2018
Medical Communications, Sales and Marketing Bristol-Myers Squibb, Flatiron health, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be …

News
veeva_event

Speakers Announced for Veeva R&D Summit, Europe

May 3, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

In the pharma industry, we tend to use a lot of acronyms. Even in every day life, we are shortening …

News

Sandoz US woes continue with biosimilar rejection

May 3, 2018
Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …

News
jeremy_hunt

450,000 missed breast cancer screenings, 270 lives potentially shortened

May 2, 2018
Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical

An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …

News
20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018
Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …

News
novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018
Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

News
praluentalirocumab_1211441

Sanofi/Regeneron forced to slash price in wake of slow sales

May 1, 2018
Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025